Analysis of more than 13 million UK patients show rates have risen sharply yet around a third of sufferers do not have potentially lifesaving EpiPens. Analysis of more than 13 million UK patients show rates have risen sharply yet around a third of sufferers do not have potentially lifesaving EpiPens.